MP for Hastings and Rye Calls Urgent Public Meeting in Defence of Hastings NHS Walk-In Centre

Local Member of Parliament for Hastings and Rye, Amber Rudd, called an urgent public meeting at Sussex Coast College on Friday, 21 September, to debate recent proposals to move Hastings NHS Walk-In Centre from its current location on Station Plaza to the Conquest Hospital. The event was attended by representatives from NHS Hastings and Rother Clinical Commissioning Group (CCG). Among the CCG delegates present at the meeting was the group’s chief officer – Amanda Philpott.

After an opening statement by Ms Philpott, residents were given the opportunity to quiz CCG delegates about the new proposals. The main issue raised was that of location, with residents expressing concerns with the plans to move the Walk-In Centre from its current location in central Hastings to the northern edge of town. Several residents made clear their opposition to the proposals, arguing that such a move would limit access to the Walk-In Centre for those who require the centre and its services the most in particular, elderly residents and visitors to Hastings.

Commenting on the occasion, Amber Rudd said: “The good turnout at the meeting held late on a Friday afternoon reflects the strength of feeling, as well as the concerns that many residents here in Hastings have with regards to these proposals. I am grateful to Peter Chowney, leader of Hastings Borough Council for attending this meeting.

Amber added: “It is important that when plans such as these are put forward, that local residents feel that they are being properly listened to. One of the most valuable assets of the NHS Walk-In Centre is its location, being located right in the centre of Hastings town. It is because of this that I am committed to working with residents to stop the proposed move of the centre away from its current central location from taking place.”

 

---End---

 

Photo: Amber Rudd is pictured with Amanda Philpott (standing) and other representatives of NHS Hastings and Rother Clinical Commissioning Group.